Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany A Traina

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Clinical Breast Cancer|June 14, 2018
Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast CancerKaren A Cadoo, Peter A Kaufman, Andrew D Seidman, et al.
Current Oncology Reports|October 3, 2024
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from TaiwanYen-Nien Hou, Susan Chimonas, Prusha Patel, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
The Cochrane Database of Systematic Reviews|April 22, 2021
PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancerAmelia M Taylor, David Lok Hang Chan, Martin Tio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Cancer|March 10, 2011
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancerDevika Gajria, Kim Feigin, Lee K Tan, et al.
JAMA Oncology|October 2, 2015
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysisRodrigo R Munhoz, Allan A L Pereira, André D Sasse, et al.
American Journal of Surgery|July 13, 2010
Determinants of outcome in elderly patients with positive sentinel lymph nodesAmer K Karam, Meier Hsu, Sujata Patil, et al.
Breast Cancer Research and Treatment|September 30, 2018
Male breast cancer: a disease distinct from female breast cancerAyca Gucalp, Tiffany A Traina, Joel R Eisner, et al.
Annals of Surgical Oncology|April 22, 2009
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodesAmer K Karam, Meier Hsu, Sujata Patil, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Clinical Breast Cancer|June 14, 2018
Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast CancerKaren A Cadoo, Peter A Kaufman, Andrew D Seidman, et al.
Current Oncology Reports|October 3, 2024
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from TaiwanYen-Nien Hou, Susan Chimonas, Prusha Patel, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
The Cochrane Database of Systematic Reviews|April 22, 2021
PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancerAmelia M Taylor, David Lok Hang Chan, Martin Tio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Cancer|March 10, 2011
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancerDevika Gajria, Kim Feigin, Lee K Tan, et al.
JAMA Oncology|October 2, 2015
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysisRodrigo R Munhoz, Allan A L Pereira, André D Sasse, et al.
American Journal of Surgery|July 13, 2010
Determinants of outcome in elderly patients with positive sentinel lymph nodesAmer K Karam, Meier Hsu, Sujata Patil, et al.
Breast Cancer Research and Treatment|September 30, 2018
Male breast cancer: a disease distinct from female breast cancerAyca Gucalp, Tiffany A Traina, Joel R Eisner, et al.
Annals of Surgical Oncology|April 22, 2009
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodesAmer K Karam, Meier Hsu, Sujata Patil, et al.
Pageof 7